As of August 28, 2026, AstraZeneca PLC (AZN) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. AstraZeneca PLC has a market capitalization of $287.95B, 1.55B shares outstanding, 1 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AZN.
Market Data
Market Cap$287.95B
Shares Outstanding1.55B
Float1.54B
Cash$7.67B
Debt$34.03B
Short InterestN/A
Institutional Holdings
1 institutional holders · 4.99M shares
#1
BARCLAYS PLC
4.99M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest1.84M
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
6-K
8K EVENT
2026-03-20
3
FORM3
2026-03-19
6-K
8K EVENT
2026-03-06
6-K
8K EVENT
2026-03-06
6-K
8K EVENT
2026-03-02
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual AZN Dilution Snapshot
AstraZeneca PLC (AZN) has a DilutionScore of 12/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for AZN: 6-K on 2026-03-20; 3 on 2026-03-19; 6-K on 2026-03-06.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track AZN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AZN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for AZN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.